REGULATIONSarepta shares skyrocket on early results for DMD gene therapyBy Bill MeagherJun 19, 2018 1:29 PM EDT
PRESS RELEASESSolid Biosciences Provides Update Regarding The IGNITE DMD Phase I/II Clinical HoldBy GlobeNewswireJul 24, 2020 5:51 PM EDT
PRESS RELEASESSolid Biosciences Announces Appointment Of Ian F. Smith As Chairman Of The Board Of DirectorsBy GlobeNewswireJun 18, 2020 7:00 AM EDT
PRESS RELEASESSolid Biosciences To Hold Virtual Annual Meeting Of Stockholders On June 16, 2020By GlobeNewswireMay 22, 2020 7:00 AM EDT
PRESS RELEASESSolid Biosciences Provides Update Regarding SGT-001 Phase I/II Clinical Hold On IGNITE DMDBy GlobeNewswireMay 7, 2020 7:22 AM EDT
PRESS RELEASESSolid Biosciences Announces Appointment Of Ian F. Smith To Its Board Of DirectorsBy GlobeNewswireApr 16, 2020 7:00 AM EDT
REGULATIONSarepta shares skyrocket on early results for DMD gene therapyBy Bill MeagherJun 19, 2018 1:29 PM EDT
HEALTHSolid Biosciences Soars 41% in IPO Despite Late Disclosure About FDA LetterBy Bill MeagherJan 26, 2018 6:45 PM EST
